Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Investigating the Interaction Between Fertility, Pregnancy, and Multiple Sclerosis Publisher



Ashtari F1 ; Mokhtari F2 ; Valiani M1 ; Soudavi M3 ; Saadat H3 ; Tolouei H4 ; Mansourian M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Midwifery, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Diseases Management Department, Isfahan University of Medical Sciences Isfahan, Deputy of Treatment, Iran
  4. 4. Isfahan University of Medical Sciences Isfahan, Deputy of Treatment, Iran
  5. 5. Department of Biostatistics and Epidemiology, Health School, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Education and Health Promotion Published:2021


Abstract

BACKGROUND: Multiple sclerosis (MS) is a chronic disease of the central nervous system. Most women with MS are diagnosed during their reproductive ages. The aim of this study was to evaluate the interaction between fertility, pregnancy, and MS. MATERIALS AND METHODS: A retrospective descriptive-analytic study was conducted on 110 women suffering from MS with a history of pregnancy (between 2007 and 2017 years) in Isfahan, Iran. Samples were selected in a census model. Women completed a researcher-constructed questionnaire by telephone. The questionnaire consisted of three parts: demographic information, MS and its symptoms and treatment, and reproductive system and the history of pregnancy associated with MS. The data were analyzed by SPSS software version 16 using Chi-square, ANOVA, and t-test. RESULTS: The mean age of women was 32.4 years. In this population, the average number of pregnancies was 1.61, the number of deliveries was 1.35, the number of abortions was 0.24, the history of ectopic pregnancy was 0.01, the number of alive children was 1.36, and the number of dead children was 0.01. The average time of the last MS attack before the pregnancy was 21.36 months. Fatigue (24.5%) was the most common symptom exacerbated during pregnancy. MS symptoms improved in 55.0% of women in the second trimester. CONCLUSIONS: MS had no effect on the pregnancy status, such as the number of abortions, ectopic pregnancy, alive and dead children, and the duration of pregnancy. Symptoms of the disease improved during pregnancy. Therefore, pregnancy has a protective role against MS. © 2021 Georg Thieme Verlag. All rights reserved.
Related Docs
View other Related Docs
1. Reciprocal Effects of Multiple Sclerosis, Childbirth, and Postpartum, Iranian Journal of Neonatology (2018)
2. Risk Factors of Early Onset of Ms in Women in Reproductive Age Period: Survival Analysis Approach, Archives of Women's Mental Health (2016)
3. Better Prognosis of Multiple Sclerosis in Patients Who Experienced a Full-Term Pregnancy, European Neurology (2012)
4. Investigation of Pregnancy Tendency, Reproductive Characteristics, and Disability in Women With Multiple Sclerosis: A Secondary Data Analysis of the National Registry in Iran, Current Journal of Neurology (2024)
5. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province, International Journal of Preventive Medicine (2016)
6. Is Fertility Affected in Women of Childbearing Age With Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?, Journal of Molecular Neuroscience (2020)
7. Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies, Journal of Neurology (2024)
8. Pregnancy and Multiple Sclerosis, Neurological Disorders and Pregnancy (2011)
Experts (# of related papers)
View all Related Experts
Vahid Shaygannejad (77)
Masoud Etemadifar (58)
Other Related Docs
9. Cesarean Delivery May Increase the Risk of Multiple Sclerosis, Multiple Sclerosis Journal (2012)
10. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
11. Estimated Prevalence and Incidence of Multiple Sclerosis in Iran, European Neurology (2014)
12. Pregnancy and Multiple Sclerosis, Neurological Disorders and Pregnancy (2010)
13. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
14. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
15. Increasing Female Preponderance of Multiple Sclerosis in Isfahan, Iran: A Population-Based Study, Multiple Sclerosis (2010)
16. The Role of Parental Consanguinity and Familial Aggregation in Development of Multiple Sclerosis: A Case-Control Study, European journal of medical research (2024)
17. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
18. Ongoing Increase in Incidence and Prevalence of Multiple Sclerosis in South-Eastern Iran: A Three Decade Study, Multiple Sclerosis and Related Disorders (2023)
19. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
20. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
21. Male Sex Is Independently Associated With Faster Disability Accumulation in Relapse-Onset Ms But Not in Primary Progressive Ms, PLoS ONE (2015)
22. Stress Differentially Predicts Multiple Sclerosis Relapses, Neurology Asia (2014)
23. Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients, International Journal of Preventive Medicine (2023)
24. Confirmed Disability Progression As a Marker of Permanent Disability in Multiple Sclerosis, European Journal of Neurology (2022)
25. Cost of Illness of Multiple Sclerosis in Isfahan, Iran, From a Social Perspective: A Comparison of the Human-Capital and Friction-Cost Methods, Value in Health Regional Issues (2022)
26. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
27. Incidence and Prevalence of Multiple Sclerosis in Persian Gulf Area: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2020)
28. Multiple Sclerosis Severity Score (Msss) Improves the Accuracy of Individualized Prediction in Ms, Multiple Sclerosis Journal (2022)
29. Environmental Risk Factors for Multiple Sclerosis: A Case-Control Study in Kerman, Iran, Iranian Journal of Nursing and Midwifery Research (2018)
30. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis, JAMA Neurology (2018)
31. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018, CNS Drugs (2021)
32. Sex As a Determinant of Relapse Incidence and Progressive Course of Multiple Sclerosis, Brain (2013)
33. Effectiveness of Bupropion on Sexual Dysfunction of Women With Multiple Sclerosis: A Clinical Trial, Iranian Journal of Obstetrics, Gynecology and Infertility (2021)
34. Sexual Dysfunction in Women With Multiple Sclerosis: Dimensions and Contributory Factors, Journal of Research in Medical Sciences (2014)
35. Estimated Incidence Rate of Multiple Sclerosis and Its Relationship With Geographical Factors in Isfahan Province Between the Years 2001 and 2014, International Journal of Preventive Medicine (2018)
36. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
37. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
38. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
39. Expectations of Multiple Sclerosis Patients and Their Families: A Qualitative Study in Iran, Iranian Red Crescent Medical Journal (2015)
40. Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies, Neurology: Neuroimmunology and NeuroInflammation (2024)
41. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
42. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)
43. Prenatal and Perinatal Factors Associated With Developing Multiple Sclerosis Later in Life: A Systematic Review and Meta-Analysis, Autoimmunity Reviews (2021)
44. Sexual Dysfunction in Women With Multiple Sclerosis: Prevalence and Impact on Quality of Life, BMC Urology (2020)
45. The Global Prevalence of Familial Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis, BMC Neurology (2021)
46. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
47. The Frequency of Cognitive Dysfunction Among Multiple Sclerosis Patients With Mild Physical Disability, Journal of Isfahan Medical School (2012)
48. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
49. Risk Factors of Multiple Sclerosis and Their Relation With Disease Severity: A Cross-Sectional Study From Iran, Archives of Iranian Medicine (2016)
50. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)